Retinoblastoma pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Retinoblastoma}} | {{Retinoblastoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{Simrat}} {{Sahar}} | ||
==Overview== | ==Overview== | ||
[[Retinoblastoma]] is a [[neoplasm]] which is caused by the inactivation of [[RB1]] [[gene]], a [[tumor suppressor gene]], located on the long arm of the [[chromosome 13]]. [[Mutation]] in both [[alleles]] of the [[RB1]] [[gene]] is necessary for the inactivation of the [[gene]]. This [[disorder]] may occur in the [[familial]] or sporadic form. ([[Rb]]) gene product limits the cell progression from the [[G1 phase]] to the [[S phase]] of the cell cycle. Loss of this active, functional [[protein]] ([[Rb]]) causes cell cycle dysregulation and subsequent overgrowth and tumor formation. | |||
==Pathogenesis== | ==Pathogenesis== | ||
*[[Retinoblastoma]] is a [[neoplasm]] which is caused by the inactivation of [[RB1]] [[gene]], a [[tumor suppressor gene]].<ref name="pmid3175621">{{cite journal |vauthors=Dunn JM, Phillips RA, Becker AJ, Gallie BL |title=Identification of germline and somatic mutations affecting the retinoblastoma gene |journal=Science |volume=241 |issue=4874 |pages=1797–800 |date=September 1988 |pmid=3175621 |doi= |url=}}</ref> | *[[Retinoblastoma]] is a [[neoplasm]] which is caused by the inactivation of [[RB1]] [[gene]], a [[tumor suppressor gene]].<ref name="pmid3175621">{{cite journal |vauthors=Dunn JM, Phillips RA, Becker AJ, Gallie BL |title=Identification of germline and somatic mutations affecting the retinoblastoma gene |journal=Science |volume=241 |issue=4874 |pages=1797–800 |date=September 1988 |pmid=3175621 |doi= |url=}}</ref> | ||
| Line 13: | Line 12: | ||
*In the sporadic form, both [[mutations]] occur during the lifetime of the individual. | *In the sporadic form, both [[mutations]] occur during the lifetime of the individual. | ||
*([[Rb]]) gene product limits the cell progression from the [[G1 phase]] to the [[S phase]] of the cell cycle.<ref name="GoodrichWang1991">{{cite journal|last1=Goodrich|first1=David W.|last2=Wang|first2=Nan Ping|last3=Qian|first3=Yue-Wei|last4=Lee|first4=Eva Y.-H.P.|last5=Lee|first5=Wen-Hwa|title=The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle|journal=Cell|volume=67|issue=2|year=1991|pages=293–302|issn=00928674|doi=10.1016/0092-8674(91)90181-W}}</ref> | *([[Rb]]) gene product limits the cell progression from the [[G1 phase]] to the [[S phase]] of the cell cycle.<ref name="GoodrichWang1991">{{cite journal|last1=Goodrich|first1=David W.|last2=Wang|first2=Nan Ping|last3=Qian|first3=Yue-Wei|last4=Lee|first4=Eva Y.-H.P.|last5=Lee|first5=Wen-Hwa|title=The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle|journal=Cell|volume=67|issue=2|year=1991|pages=293–302|issn=00928674|doi=10.1016/0092-8674(91)90181-W}}</ref> | ||
*Active [[Rb]] protein binds to [[E2F]], a [[transcription factor]]. Loss of this active, functional [[protein]] ([[Rb]]) causes cell cycle dysregulation. | *Active [[Rb]] protein binds to [[E2F]], a [[transcription factor]]. Loss of this active, functional [[protein]] ([[Rb]]) causes cell cycle dysregulation and subsequent overgrowth and tumor formation. | ||
==Genetics== | ==Genetics== | ||
*[[Retinoblastoma]] occurs due to [[Mutation|mutational]] inactivation of [[RB1]] [[gene]] located on the [[chromosome 13]].<ref name="pmid5279523">{{cite journal |vauthors=Knudson AG |title=Mutation and cancer: statistical study of retinoblastoma |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=68 |issue=4 |pages=820–3 |date=April 1971 |pmid=5279523 |pmc=389051 |doi= |url=}}</ref> | *[[Retinoblastoma]] occurs due to [[Mutation|mutational]] inactivation of [[RB1]] [[gene]] located on the [[chromosome 13]].<ref name="pmid5279523">{{cite journal |vauthors=Knudson AG |title=Mutation and cancer: statistical study of retinoblastoma |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=68 |issue=4 |pages=820–3 |date=April 1971 |pmid=5279523 |pmc=389051 |doi= |url=}}</ref> | ||
| Line 27: | Line 26: | ||
*[[Mosaicism]], presence of [[RB1]] [[gene mutation]] in some not all the [[cells]] of the affected person, may occur in [[retinoblastoma]]. | *[[Mosaicism]], presence of [[RB1]] [[gene mutation]] in some not all the [[cells]] of the affected person, may occur in [[retinoblastoma]]. | ||
**Patients with [[Mosaicism|mosaic mutation]] often have unilateral [[retinoblastoma]], later onset of the [[tumor]] and no [[family history]] of the [[disease]]. | **Patients with [[Mosaicism|mosaic mutation]] often have unilateral [[retinoblastoma]], later onset of the [[tumor]] and no [[family history]] of the [[disease]]. | ||
==Gross Pathology== | ==Gross Pathology== | ||
*[[Macroscopic]] appearance of the [[tumor]] varies according to the [[Cancer staging|staging]] of the [[tumor]].<ref name="pmid24881618">{{cite journal |vauthors=Das D, Bhattacharjee K, Barthakur SS, Tahiliani PS, Deka P, Bhattacharjee H, Deka A, Paul R |title=A new rosette in retinoblastoma |journal=Indian J Ophthalmol |volume=62 |issue=5 |pages=638–41 |date=May 2014 |pmid=24881618 |pmc=4065523 |doi=10.4103/0301-4738.129786 |url=}}</ref> | *[[Macroscopic]] appearance of the [[tumor]] varies according to the [[Cancer staging|staging]] of the [[tumor]].<ref name="pmid24881618">{{cite journal |vauthors=Das D, Bhattacharjee K, Barthakur SS, Tahiliani PS, Deka P, Bhattacharjee H, Deka A, Paul R |title=A new rosette in retinoblastoma |journal=Indian J Ophthalmol |volume=62 |issue=5 |pages=638–41 |date=May 2014 |pmid=24881618 |pmc=4065523 |doi=10.4103/0301-4738.129786 |url=}}</ref> | ||
| Line 49: | Line 47: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Growth occurs inwards into the [[vitreous]] | *Growth occurs inwards into the [[vitreous]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
| Line 56: | Line 53: | ||
*Growth occurs outwards toward [[choroid]] | *Growth occurs outwards toward [[choroid]] | ||
*Associated with non-rhegmatogenous [[retinal detachment]] | *Associated with non-rhegmatogenous [[retinal detachment]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
| Line 63: | Line 59: | ||
*Most common type | *Most common type | ||
*Mixed components of endophytic and exophytic are seen | *Mixed components of endophytic and exophytic are seen | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
| Line 72: | Line 67: | ||
*Frequently involve [[anterior chamber]] and cause pseudohypopyon of [[Tumor cell|tumor cells]] | *Frequently involve [[anterior chamber]] and cause pseudohypopyon of [[Tumor cell|tumor cells]] | ||
*Clinically can be mistaken with an [[inflammatory process]] | *Clinically can be mistaken with an [[inflammatory process]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
| Line 79: | Line 73: | ||
*May present as an [[inflammatory process]] and be mistaken for [[orbital cellulitis]] with [[chemosis]] and [[proptosis]] | *May present as an [[inflammatory process]] and be mistaken for [[orbital cellulitis]] with [[chemosis]] and [[proptosis]] | ||
*Associated with increased risk of [[metastasis]] | *Associated with increased risk of [[metastasis]] | ||
|- | |- | ||
|} | |} | ||
| Line 87: | Line 80: | ||
|- | |- | ||
|} | |} | ||
==Microscopic Pathology== | ==Microscopic Pathology== | ||
[[Microscopic|Microscopically]], [[retinoblastoma]] is a [[neoplasm]] consists of:<ref name="pmid22288967">{{cite journal |vauthors=Kashyap S, Sethi S, Meel R, Pushker N, Sen S, Bajaj MS, Chandra M, Ghose S |title=A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country |journal=Arch. Pathol. Lab. Med. |volume=136 |issue=2 |pages=190–3 |date=February 2012 |pmid=22288967 |doi=10.5858/arpa.2010-0759-OA |url=}}</ref> | [[Microscopic|Microscopically]], [[retinoblastoma]] is a [[neoplasm]] consists of:<ref name="pmid22288967">{{cite journal |vauthors=Kashyap S, Sethi S, Meel R, Pushker N, Sen S, Bajaj MS, Chandra M, Ghose S |title=A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country |journal=Arch. Pathol. Lab. Med. |volume=136 |issue=2 |pages=190–3 |date=February 2012 |pmid=22288967 |doi=10.5858/arpa.2010-0759-OA |url=}}</ref> | ||
| Line 108: | Line 100: | ||
*Mild (25%-50%) | *Mild (25%-50%) | ||
*Extensive (>50%) | *Extensive (>50%) | ||
==Immunohistochemistry== | ==Immunohistochemistry== | ||
*There is no specific [[immunohistochemical]] [[marker]] for the [[diagnosis]] of retinoblastoma.<ref name="pmid16049534">{{cite journal |vauthors=Odashiro AN, Pereira PR, de Souza Filho JP, Cruess SR, Burnier MN |title=Retinoblastoma in an adult: case report and literature review |journal=Can. J. Ophthalmol. |volume=40 |issue=2 |pages=188–91 |date=April 2005 |pmid=16049534 |doi=10.1016/S0008-4182(05)80032-8 |url=}}</ref><ref name="pmid23166876">{{cite journal |vauthors=Zhang Z, Shi JT, Wang NL, Ma JM |title=Retinoblastoma in a young adult mimicking Coats' disease |journal=Int J Ophthalmol |volume=5 |issue=5 |pages=625–9 |date=2012 |pmid=23166876 |pmc=3484701 |doi=10.3980/j.issn.2222-3959.2012.05.16 |url=}}</ref> | *There is no specific [[immunohistochemical]] [[marker]] for the [[diagnosis]] of retinoblastoma.<ref name="pmid16049534">{{cite journal |vauthors=Odashiro AN, Pereira PR, de Souza Filho JP, Cruess SR, Burnier MN |title=Retinoblastoma in an adult: case report and literature review |journal=Can. J. Ophthalmol. |volume=40 |issue=2 |pages=188–91 |date=April 2005 |pmid=16049534 |doi=10.1016/S0008-4182(05)80032-8 |url=}}</ref><ref name="pmid23166876">{{cite journal |vauthors=Zhang Z, Shi JT, Wang NL, Ma JM |title=Retinoblastoma in a young adult mimicking Coats' disease |journal=Int J Ophthalmol |volume=5 |issue=5 |pages=625–9 |date=2012 |pmid=23166876 |pmc=3484701 |doi=10.3980/j.issn.2222-3959.2012.05.16 |url=}}</ref> | ||
| Line 119: | Line 110: | ||
**[[Immunocytochemistry|IHC]] may be useful for the identification of [[photoreceptors]] and [[glial cells]] in the retinoblastoma. | **[[Immunocytochemistry|IHC]] may be useful for the identification of [[photoreceptors]] and [[glial cells]] in the retinoblastoma. | ||
*[[Immunocytochemistry|IHC]] may also be useful in identifying the level of differentiation of the [[tumor]] by detecting red and green [[cones]] found in rosettes and fleurettes and blue [[cones]] which do not form rosettes and fleurettes. | *[[Immunocytochemistry|IHC]] may also be useful in identifying the level of differentiation of the [[tumor]] by detecting red and green [[cones]] found in rosettes and fleurettes and blue [[cones]] which do not form rosettes and fleurettes. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:02, 16 May 2019
|
Retinoblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Retinoblastoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Retinoblastoma pathophysiology |
|
Risk calculators and risk factors for Retinoblastoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Sahar Memar Montazerin, M.D.[3]
Overview
Retinoblastoma is a neoplasm which is caused by the inactivation of RB1 gene, a tumor suppressor gene, located on the long arm of the chromosome 13. Mutation in both alleles of the RB1 gene is necessary for the inactivation of the gene. This disorder may occur in the familial or sporadic form. (Rb) gene product limits the cell progression from the G1 phase to the S phase of the cell cycle. Loss of this active, functional protein (Rb) causes cell cycle dysregulation and subsequent overgrowth and tumor formation.
Pathogenesis
- Retinoblastoma is a neoplasm which is caused by the inactivation of RB1 gene, a tumor suppressor gene.[1]
- Normally, RB1 gene is necessary for the normal differentiation and growth of retinal stem cells and its mutation results in unregulated growth of these cells and development of the tumor.
- Mutation in both alleles of the RB1 gene is necessary for the inactivation of the gene.[2]
- This disorder may occur in the familial or sporadic form.
- In the familial form (48% of the cases), the first mutation occurs during germ cell division and the second one later during the division of somatic cells.[3]
- In the sporadic form, both mutations occur during the lifetime of the individual.
- (Rb) gene product limits the cell progression from the G1 phase to the S phase of the cell cycle.[4]
- Active Rb protein binds to E2F, a transcription factor. Loss of this active, functional protein (Rb) causes cell cycle dysregulation and subsequent overgrowth and tumor formation.
Genetics
- Retinoblastoma occurs due to mutational inactivation of RB1 gene located on the chromosome 13.[5]
- The RB1 gene acts as tumor suppressor gene.[6]
- Two mutational events are needed for the development of retinoblastoma.
- In familial form, with autosomal dominant inheritance, one mutation occurs in the germline and the second one during the somatic division of the retinal cells.
- In the acquired form, both mutations occur during somatic divisions.
- Another gene which has been associated with the pathogenesis of retinoblastoma is MYCN gene.[7]
- Retinoblastoma may also occur as part of 13q deletion syndrome.[8]
- This syndrome is the result of the deletion of the long arm of chromosome 13.
- Symptoms may vary according to the size of the deletion, but it may lead to developmental delay as well.
- Children with chromosome 13q14 deletions may develop retinoblastoma at a later age and they develop a unilateral tumor.
- Mosaicism, presence of RB1 gene mutation in some not all the cells of the affected person, may occur in retinoblastoma.
- Patients with mosaic mutation often have unilateral retinoblastoma, later onset of the tumor and no family history of the disease.
Gross Pathology
- Macroscopic appearance of the tumor varies according to the staging of the tumor.[9]
- The tumor is white and has areas of calcification and necrosis.
- The presence of calcium is more noticeable when the tumor was treated via prior chemotherapy or radiotherapy.
- The tumor can be classified into five sub-group according to its growth pattern. These patterns are recognizable grossly.[10]
- Endophytic
- Exophytic
- Mixed
- Diffuse infiltrative
- Necrotic variant
These growth pattern are described in the below table:
| Growth patterns | Features |
|---|---|
|
|
|
|
|
|
|
|
|
|
|
Microscopic Pathology
Microscopically, retinoblastoma is a neoplasm consists of:[11]
- Small hyperchromatic cells with a high nuclear to cytoplasmic ratio
- Large areas of necrosis
- Multifocal area of calcifications
Retinoblastoma histopathology is a combination of undifferentiated cells and areas of tumor differentiation shown as rosettes and fleurettes.[12]
- The most differentiated part is formed from a bouquet-like aggregates of cells called fleurettes, where mitoses or necrosis are not present.
- These cells resembled the photoreceptors and arranged similar to flowers.
- Rostte formations composed of cells with varing degrees of differentiation.
- There are two types of rosettes:
- Flexner–Wintersteiner rosette that composed of a ring of cells sorrounding a clear center resembling the subretinal space.
- Homer Wright rosette that comprise of a rim of cells with a lumen filled by cytoplasmic prolongations of the tumor cells.
- Both may contains mitotic figures.
Retinoblastoma may be classified according to the degree of differentiation to well/poor-differentiated.
- Well-differentiated tumor is known as >50% Homer-Wright (HW) rosettes.
- Poor-differentiated tumor is known as <50% Flexner-Wintersteiner (FW) rosettes.
Also, the tumor is graded according to the presence and degree of necrosis as follows:[13]
- None (<25%)
- Mild (25%-50%)
- Extensive (>50%)
Immunohistochemistry
- There is no specific immunohistochemical marker for the diagnosis of retinoblastoma.[14][15]
- The most commonly applied marker is neuron specific enolase (NSE)
- Other useful markers are such as:
- Although there is no specific biomarker for the diagnosis of retinoblastoma, it may be needed for the diagnosis of undifferentiated form of the tumor.[16][17]
- IHC may be useful for the identification of photoreceptors and glial cells in the retinoblastoma.
- IHC may also be useful in identifying the level of differentiation of the tumor by detecting red and green cones found in rosettes and fleurettes and blue cones which do not form rosettes and fleurettes.
References
- ↑ Dunn JM, Phillips RA, Becker AJ, Gallie BL (September 1988). "Identification of germline and somatic mutations affecting the retinoblastoma gene". Science. 241 (4874): 1797–800. PMID 3175621.
- ↑ Dunn JM, Phillips RA, Zhu X, Becker A, Gallie BL (November 1989). "Mutations in the RB1 gene and their effects on transcription". Mol. Cell. Biol. 9 (11): 4596–604. PMC 363605. PMID 2601691.
- ↑ Garber JE, Offit K (January 2005). "Hereditary cancer predisposition syndromes". J. Clin. Oncol. 23 (2): 276–92. doi:10.1200/JCO.2005.10.042. PMID 15637391.
- ↑ Goodrich, David W.; Wang, Nan Ping; Qian, Yue-Wei; Lee, Eva Y.-H.P.; Lee, Wen-Hwa (1991). "The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle". Cell. 67 (2): 293–302. doi:10.1016/0092-8674(91)90181-W. ISSN 0092-8674.
- ↑ Knudson AG (April 1971). "Mutation and cancer: statistical study of retinoblastoma". Proc. Natl. Acad. Sci. U.S.A. 68 (4): 820–3. PMC 389051. PMID 5279523.
- ↑ Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986). "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma". Nature. 323 (6089): 643–6. doi:10.1038/323643a0. PMID 2877398.
- ↑ Fabian ID, Rosser E, Sagoo MS (2018). "Epidemiological and genetic considerations in retinoblastoma". Community Eye Health. 31 (101): 29–30. PMC 5998388. PMID 29915469.
- ↑ Clark, Robin D.; Avishay, Stefanie G. (2015). "Retinoblastoma: Genetic Counseling and Testing": 77–88. doi:10.1007/978-3-662-43451-2_8.
- ↑ Das D, Bhattacharjee K, Barthakur SS, Tahiliani PS, Deka P, Bhattacharjee H, Deka A, Paul R (May 2014). "A new rosette in retinoblastoma". Indian J Ophthalmol. 62 (5): 638–41. doi:10.4103/0301-4738.129786. PMC 4065523. PMID 24881618.
- ↑ Singh, Arun (2015). Clinical ophthalmic oncology : retinoblastoma. Heidelberg: Springer. ISBN 978-3-662-43451-2.
- ↑ Kashyap S, Sethi S, Meel R, Pushker N, Sen S, Bajaj MS, Chandra M, Ghose S (February 2012). "A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country". Arch. Pathol. Lab. Med. 136 (2): 190–3. doi:10.5858/arpa.2010-0759-OA. PMID 22288967.
- ↑ Chévez-Barrios, Patricia; Eagle, Ralph C.; Marback, Eduardo F. (2015). "Histopathologic Features and Prognostic Factors": 167–183. doi:10.1007/978-3-662-43451-2_16.
- ↑ Singh L, Pushker N, Sen S, Singh MK, Chauhan FA, Kashyap S (August 2015). "Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters". Clin. Experiment. Ophthalmol. 43 (6): 550–7. doi:10.1111/ceo.12517. PMID 25754767.
- ↑ Odashiro AN, Pereira PR, de Souza Filho JP, Cruess SR, Burnier MN (April 2005). "Retinoblastoma in an adult: case report and literature review". Can. J. Ophthalmol. 40 (2): 188–91. doi:10.1016/S0008-4182(05)80032-8. PMID 16049534.
- ↑ Zhang Z, Shi JT, Wang NL, Ma JM (2012). "Retinoblastoma in a young adult mimicking Coats' disease". Int J Ophthalmol. 5 (5): 625–9. doi:10.3980/j.issn.2222-3959.2012.05.16. PMC 3484701. PMID 23166876.
- ↑ Yousef YA, Istetieh J, Nawaiseh I, Al-Hussaini M, Alrawashdeh K, Jaradat I, Sultan I, Mehyar M (September 2014). "Resistant retinoblastoma in a 23-year-old patient". Oman J Ophthalmol. 7 (3): 138–40. doi:10.4103/0974-620X.142597. PMC 4220401. PMID 25378879.
- ↑ Takahashi T, Tamura S, Inoue M, Isayama Y, Sashikata T (February 1983). "Retinoblastoma in a 26-year-old adult". Ophthalmology. 90 (2): 179–83. PMID 6856254.